Aditi Dutt

Array ( [id] => 5309678 [patent_doc_number] => 20090016959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Delivery of antibodies to the central nervous system' [patent_app_type] => utility [patent_app_number] => 11/807597 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19868 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20090016959.pdf [firstpage_image] =>[orig_patent_app_number] => 11807597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12253022 [patent_doc_number] => 09925151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Cladribine regimen for treating multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 12/301083 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23513 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12301083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765749 [patent_doc_number] => 20080176961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain' [patent_app_type] => utility [patent_app_number] => 11/801400 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 33269 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176961.pdf [firstpage_image] =>[orig_patent_app_number] => 11801400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585957 [patent_doc_number] => 20090105159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Neuroprotective Compounds and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/299463 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7909 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105159.pdf [firstpage_image] =>[orig_patent_app_number] => 12299463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888040 [patent_doc_number] => 09758593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Compositions and methods for treating cocaine-related disorders' [patent_app_type] => utility [patent_app_number] => 11/788808 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9488 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11788808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380360 [patent_doc_number] => 20090192199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/297616 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29747 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192199.pdf [firstpage_image] =>[orig_patent_app_number] => 12297616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691260 [patent_doc_number] => 08821851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Inflammation-inhibitory serum factors and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/225496 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 24952 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652133 [patent_doc_number] => 20080039389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'DOSING REGIMENS FOR NEURAL STEM CELL PROLIFERATING AGENTS AND DIFFERENTIATING AGENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/687302 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12971 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039389.pdf [firstpage_image] =>[orig_patent_app_number] => 11687302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4978120 [patent_doc_number] => 20070219354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity' [patent_app_type] => utility [patent_app_number] => 11/714985 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33048 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219354.pdf [firstpage_image] =>[orig_patent_app_number] => 11714985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6501189 [patent_doc_number] => 20100215722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Tissue Regeneration II' [patent_app_type] => utility [patent_app_number] => 12/224470 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14551 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215722.pdf [firstpage_image] =>[orig_patent_app_number] => 12224470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199680 [patent_doc_number] => 20070298998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Biomarkers for amyotrophic lateral sclerosis and methods using the same' [patent_app_type] => utility [patent_app_number] => 11/711518 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 53472 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298998.pdf [firstpage_image] =>[orig_patent_app_number] => 11711518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500250 [patent_doc_number] => 20100215663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/279499 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9354 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215663.pdf [firstpage_image] =>[orig_patent_app_number] => 12279499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455329 [patent_doc_number] => 07892573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Nerve regeneration employing keratin biomaterials' [patent_app_type] => utility [patent_app_number] => 11/673212 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 12480 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892573.pdf [firstpage_image] =>[orig_patent_app_number] => 11673212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063004 [patent_doc_number] => 20070224644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Ocular fluid markers' [patent_app_type] => utility [patent_app_number] => 11/698998 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 81133 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224644.pdf [firstpage_image] =>[orig_patent_app_number] => 11698998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055658 [patent_doc_number] => 20110112018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Method for the Treatment and/or Prophylaxis of Multiple Sclerosis, and Use of Erythropoietin for the Manufacture of a Medicament for the Intermittent and/or Intermittent Prophylaxis of Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 12/223197 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1639 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112018.pdf [firstpage_image] =>[orig_patent_app_number] => 12223197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4976853 [patent_doc_number] => 20070218084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy' [patent_app_type] => utility [patent_app_number] => 11/623568 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10737 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218084.pdf [firstpage_image] =>[orig_patent_app_number] => 11623568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386276 [patent_doc_number] => 20090227521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'USE OF COMPOUNDS IN THE TREATMENT OF ISCHEMIA AND NEURODEGENERATION' [patent_app_type] => utility [patent_app_number] => 12/160786 [patent_app_country] => US [patent_app_date] => 2007-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11395 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227521.pdf [firstpage_image] =>[orig_patent_app_number] => 12160786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219664 [patent_doc_number] => 20070160975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method for the Identification of Drugs to Treat Stroke at Delayed Timepoints' [patent_app_type] => utility [patent_app_number] => 11/621196 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3079 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160975.pdf [firstpage_image] =>[orig_patent_app_number] => 11621196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236428 [patent_doc_number] => 20070128585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => '(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION' [patent_app_type] => utility [patent_app_number] => 11/615520 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13362 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128585.pdf [firstpage_image] =>[orig_patent_app_number] => 11615520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292076 [patent_doc_number] => 07544365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'TRPV1+ sensory neurons control of β-cells stress and islet inflammation in diabetes' [patent_app_type] => utility [patent_app_number] => 11/638830 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 62 [patent_no_of_words] => 7992 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544365.pdf [firstpage_image] =>[orig_patent_app_number] => 11638830 [rel_patent_id] =>[rel_patent_doc_number] =>)